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Evidence suggests physical activity improves prognosis following cancer diagnosis; 
however, evidence regarding prognosis in long-term survivors of cancer is scarce. 
We assessed physical activity in 1,589 cancer survivors at an average 8.8 years fol-
lowing their initial diagnosis and calculated their future mortality risk following physical 
activity assessment. We also selected a cancer-free cohort of 3,145 age, sex, and 
survey year group-matched cancer-free individuals from the same source population 
for comparison purposes. Risks for cancer-specific mortality and all-cause mortality 
in relation to physical activity levels were estimated using Cox regression proportional 
hazard regression analyses within the cancer and non-cancer cohorts. Physical activity 
levels of 360+ min per week were inversely associated with cancer-specific mortality 
in long-term cancer survivors [hazard ratios (HR) = 0.30 (95% confidence intervals (CI) 
0.13–0.70)] and participants without prior cancer [HR = 0.16 (95% CI 0.05–0.56)] com-
pared with no reported physical activity. Physical activity levels of 150–359 and 360+ 
min were inversely associated with all-cause mortality in long-term cancer survivors 
[150–359 min; HR = 0.55 (95% CI 0.31–0.97), 360+ min; HR = 0.41 (95% CI 0.21–
0.79)] and those without prior cancer [150–359 min; HR = 0.52 (95% CI 0.32–0.86), 
360+ min; HR = 0.50 (95% CI 0.29–0.88)]. These results suggest that meeting exercise 
guidelines of 150 min of physical activity per week were associated with reduced all-
cause mortality in both long-term cancer surviving and cancer-free cohorts. Exceeding 
exercise oncology guidelines (360+ min per week) may provide additional protection in 
terms of cancer-specific death.
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inTrODUcTiOn
Identification and management of lifestyle risk factors affecting 
prognosis in cancer survivors is becoming increasingly impor-
tant as cancer screening and treatments continue to improve. 
In Australia, the number of cancers diagnosed almost doubled 
between 1991 and 2009, with a corresponding increase in age-
standardized incidence of 12% (1). During a similar period of 
time, 5-year relative survival following any cancer diagnosis 
increased from 47% in 1982–1987 to 66% in 2006–2010 (1).
Assessment of physical activity levels and their effects in 
those who survived cancer has been undertaken by a number of 
researchers (2, 3); however, the usual period of assessment has 
been within a relatively short period following cancer diagnosis 
(almost exclusively less than 2 years). These studies have gener-
ally shown positive associations between increasing levels of 
physical activity and improved quality of life, cancer-specific 
mortality, and all-cause mortality for survivors of certain cancer 
types, particularly breast (4), colorectal (5–7), and prostate (8) 
cancer. Additionally, it has been suggested that cancer recurrence 
might be positively impacted by physical activity levels post-
diagnosis, although evidence appears contradictory (9–12). To 
date, however, assessment of physical activity levels in terms of 
their effects on mortality in long-term survivors has been almost 
non-existent, although a recent study by Inoue-Choi et al. (13) 
suggested improved survival benefits for cancer survivors may 
be associated with adherence to the recommended physical 
activity guidelines. With improved long-term survival in those 
diagnosed with cancer, it is important to understand whether the 
survival benefits associated with physical activity extend beyond 
the immediate rehabilitation stage associated with cancer (and 
treatment) recovery. Moreover, it is important to assess whether 
physical activity behaviors contribute similar benefits in these 
long-term cancer survivors, compared to cancer-naive individu-
als. By linking the Western Australian Cancer Registry dataset 
with the Western Australian Health and Wellbeing Surveillance 
System (HWSS) dataset, we were able to obtain self-reported 
leisure-time physical activity (LTPA) levels at time points 
between 2 and 28 years following first recorded cancer diagnosis. 
This allowed us to investigate whether long-term survivors of 
“any cancer” benefited from increased physical activity, in terms 
of future cancer-specific and all-cause mortality risk.
MaTerials anD MeThODs
ethics statement
The study was approved by the Human Research Ethics 
Committees of Edith Cowan University and the Western 
Australian Department of Health and has therefore been per-
formed in accordance with the ethical standards laid down in the 
1964 Declaration of Helsinki and its later amendments.
study Design
This population-based cohort study utilized self-reported life-
style survey information (from the HWSS) individually linked 
with cancer registry data (both held by the Western Australian 
Department of Health). The HWSS is a comprehensive monthly 
survey commissioned by the Western Australian Department of 
Health to provide information on a wide range of issues pertain-
ing to the Western Australian population’s physical and mental 
well-being. It utilizes computer-assisted telephone interviewing 
to assess approximately 6,000 Western Australians each year 
who are selected from the WA White Pages® telephone directory 
using a stratified random process with over-sampling representa-
tive to the population in rural and remote areas. Each year since 
its inception, more than 75% of those contacted completed the 
survey (14) and a majority (77% in 2010) of participants provided 
their name, address, and date of birth for the purpose of linkage 
with administrative health data. Only those HWSS participants 
who provided consent for their information to be used in this 
manner were linked to other registries for this study. The proba-
bilistic matching procedures used to link individuals are based 
on full name and address, phonetic compression algorithms, 
and other identifiers, and they have been estimated to be 99.89% 
accurate (15). This linkage allowed identification of incident 
cancer diagnoses prior to an initial survey date and provided 
information on behavioral factors and demographics at the time 
of survey. Mortality data were obtained through linking to the 
Western Australian Mortality Registry for the entire study period 
(2004–2011).
study Population
Between May 1, 2004 and January 1, 2011, some 44,317 
surveys for which consent was provided for data linkage 
were completed as part of the HWSS. Where participants 
had been surveyed more than once (1,616 people) during 
the study period, their last survey was included for analysis. 
Upon further restriction to those aged 40+ years, to target 
adult cancers only, 25,433 participants remained. Those with 
a diagnosed cancer (other than non-melanoma skin cancer) 
after 1982 and more than 2  years prior to their survey date 
were identified (1,813). Their first cancer within this period 
was considered their incident cancer. After further exclusion 
of cancer survivors with multiple cancers diagnosed prior to 
the survey, a cohort of 1,667 cancer survivors was selected. 
Exclusion of a further 78 individuals with missing informa-
tion for body mass index (BMI), alcohol consumption, and/
or SF-8 questions (Table  1) left a cancer survivor cohort of 
1,589. These participants were surveyed on average 8.8 years 
(quartile 1 = 4 years, quartile 3 = 12 years) following their first 
recorded cancer diagnosis.
A non-cancer cohort (NCC) was selected from the same 
source population of 44,317 individuals. Stratified random 
sampling without replacement at a ratio of 2:1 was performed 
using the age (10-year age blocks from 40 years onward), sex, 
and survey year frequency distributions of the 1,667 cancer 
survivors identified previously. This was performed using 
the “proc surveyselect” function within SAS Inc. software 
(version 9.3). The resulting 3,334 individuals had no cancer 
diagnosis prior to their survey (Table  2). After exclusion of 
189 individuals with missing data for BMI and SF-8 questions, 
a final 3,145 cancer-free individuals were included in the final 
analyses.
TaBle 2 | non-cancer cohort: baseline characteristics by level of 
leisure-time physical activity (lTPa) in survey participants without a prior 
recorded cancer diagnosis.
no lTPa 
(n = 886)
<150 min 
lTPa 
(n = 882)
150–
359 min 
lTPa 
(n = 801)
360+ 
min lTPa 
(n = 765)
n (%) n (%) n (%) n (%)
Male* 407 (45.9) 353 (40.0) 339 (42.3) 399 (52.2)
Age at survey (years)*
 40–49 42 (4.7) 49 (5.6) 55 (6.9) 68 (8.9)
 50–59 108 (12.2) 149 (16.9) 165 (20.6) 168 (22.0)
 60–69 239 (27.0) 232 (26.3) 267 (33.3) 268 (35.0)
 70–79 286 (32.3) 284 (32.2) 225 (28.1) 205 (26.8)
 80+ 211 (23.8) 168 (19.0) 89 (11.1) 56 (7.3)
Body mass index (kg/m2)*
 <25 290 (32.7) 315 (35.7) 359 (44.8) 336 (43.9)
 25–29 315 (35.6) 303 (34.4) 284 (35.5) 306 (40.0)
 30+ 197 (22.2) 208 (23.6) 132 (16.5) 102 (13.3)
 Missing 84 (9.5) 56 (6.4) 26 (3.2) 21 (2.8)
Daily fruit and/or vegetable 
intake*
 <4 servings 276 (31.2) 234 (26.5) 167 (20.8) 146 (19.1)
 4–5 servings 323 (36.5) 336 (38.1) 283 (35.3) 276 (36.1)
 6 servings 125 (14.1) 157 (17.8) 152 (19.0) 129 (16.9)
 7+ servings 162 (18.3) 155 (17.6) 199 (24.8) 214 (28.0)
Smoking status*
 Never 393 (44.4) 479 (54.3) 411 (51.3) 370 (48.4)
 Ex-smoker 349 (39.4) 307 (34.8) 330 (41.2) 338 (44.2)
 Current 144 (16.2) 96 (10.9) 60 (7.5) 57 (7.4)
Alcohol consumption (# 
drinks on any given day)*
 None 335 (37.8) 316 (35.8) 220 (27.5) 170 (22.2)
 ≤2 standard drinks 417 (47.1) 441 (50.0) 441 (55.1) 415 (54.2)
 >2 standard drinks 134 (15.1) 125 (14.2) 140 (17.5) 180 (23.5)
 Missing 0 0 0 0
SF-8 physical health 
component score*
 PCS < 50 563 (63.5) 446 (50.6) 305 (38.1) 224 (29.3)
 PCS ≥ 50 322 (36.3) 436 (49.4) 495 (61.8) 541 (70.7)
 Missing 1 (0.1) 0 1 (0.1) 0
SF-8 mental health 
component score*
 MCS < 54 443 (50.0) 421 (47.7) 338 (42.2) 293 (38.3)
 MCS ≥ 54 442 (49.9) 461 (52.3) 462 (57.7) 472 (61.7)
 Missing 1 (0.1) 0 1 (0.1) 0
Diabetes mellitus (% yes)* 129 (14.6) 120 (13.6) 80 (10.0) 62 (8.1)
*Significantly associated with LTPA (p < 0.05).
TaBle 1 | cancer survivor cohort: baseline characteristics by level of 
leisure-time physical activity (lTPa), in participants surveyed an average 
of 8.8 years following initial reported cancer diagnosis.
no lTPa 
(n = 439)
<150 min 
lTPa 
(n = 460)
150–
359 min 
lTPa 
(n = 384)
360+ 
min lTPa 
(n = 384)
n (%) n (%) n (%) n (%)
Male 205 (46.7) 187 (40.6) 173 (45.0) 184 (47.9)
Age at survey (years)*
 40–49 18 (4.1) 28 (6.1) 26 (6.8) 35 (9.1)
 50–59 58 (13.2) 86 (18.7) 75 (19.5) 76 (25.8)
 60–69 111 (25.3) 133 (28.9) 122 (31.8) 137 (27.2)
 70–79 146 (33.3) 138 (30.0) 114 (29.7) 102 (26.6)
 80+ 106 (24.2) 75 (16.3) 47 (12.2) 34 (8.8)
Body mass index (kg/m2)*
 <25 131 (29.8) 168 (36.5) 137 (35.7) 134 (34.9)
 25–29 157 (35.8) 155 (33.7) 159 (41.4) 162 (42.2)
 30+ 119 (27.1) 120 (26.1) 74 (19.3) 76 (19.8)
 Missing 32 (7.3) 17 (3.7) 14 (3.6) 12 (3.1)
Daily fruit and/or vegetable 
intake*
 <4 servings 129 (29.4) 106 (23.0) 87 (22.7) 63 (16.4)
 4–5 servings 172 (39.2) 191 (41.5) 126 (32.8) 142 (37.0)
 6 servings 64 (14.6) 84 (18.3) 69 (18.0) 63 (16.4)
 7+ servings 74 (16.9) 79 (17.2) 102 (26.6) 116 (30.2)
Smoking status
 Never 187 (42.6) 220 (47.8) 188 (49.0) 176 (45.8)
 Ex-smoker 202 (46.0) 194 (42.2) 161 (41.9) 181 (47.1)
 Current 50 (11.4) 46 (10.0) 35 (9.1) 27 (7.0)
Alcohol consumption (# 
drinks on any given day)*
 None 165 (37.6) 169 (36.7) 104 (27.1) 95 (24.7)
 ≤2 standard drinks 199 (45.3) 223 (48.5) 197 (51.3) 197 (51.3)
 >2 standard drinks 75 (17.1) 67 (14.6) 83 (21.6) 92 (24.0)
 Missing 0 1 (0.2) 0 0
SF-8 physical health 
component score*
 PCS < 50 300 (68.3) 267 (58.0) 180 (46.9) 127 (33.1)
 PCS ≥ 50 137 (31.2) 193 (42.0) 204 (53.1) 256 (66.7)
 Missing 2 (0.5) 0 0 1 (0.3)
SF-8 mental health 
component score*
 MCS < 54 231 (52.6) 247 (53.7) 181 (47.1) 154 (40.1)
 MCS ≥ 54 206 (46.9) 213 (46.3) 203 (52.9) 229 (59.6)
 Missing 2 (0.5) 0 0 1 (0.3)
 Diabetes mellitus (% yes)* 77 (17.5) 62 (13.5) 34 (8.8) 24 (6.2)
Previous cancer type
 Breast 98 (22.3) 107 (23.3) 88 (22.9) 79 (20.6)
 Prostate 75 (17.1) 78 (17.0) 57 (14.8) 70 (18.2)
 Colorectal 50 (11.4) 56 (12.2) 55 (14.3) 43 (11.2)
 Melanoma 76 (17.3) 84 (18.3) 70 (18.2) 91 (23.7)
 Other 140 (33.9) 135 (29.4) 114 (29.7) 101 (26.3)
Years from diagnosis to 
survey [mean (Q1–Q3)] 
(mean = 8.82; 4–12)
9.2 (5–13) 8.7 (4–12) 8.6 (4–12) 8.7 (4–13)
*Significantly associated with LTPA (p < 0.05).
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study Variables
Participants were asked to estimate the number of sessions and 
minutes per session of LTPA during the past week, in terms of 
walking 10 or more minutes consecutively, performing moderate 
physical activity (e.g., golf, gentle swimming, and lawn bowls), 
or vigorous physical activity (e.g., tennis, jogging, and cycling). 
Using recommendations of the Australian Institute of Health and 
Welfare (16), total LTPA was calculated using the formula [total 
LTPA =  walk-time +  moderate-time +  (2 ×  vigorous-time)]. 
Sufficient LTPA was defined as follows: no LTPA, <150  min 
LTPA, 150–359 min LTPA, or 360+ min LTPA per week. While 
Australian physical activity guidelines (16) collapse the upper 
two categories (150–359 min and 360+ min), given the approxi-
mately equal number of participants in the two upper categories, 
4Gunnell et al. Physical Activity and Cancer Survival
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stratification was preferable in this instance. For those aged 65+ 
years, no weighting was applied for vigorous physical activity in 
order to improve comparability between years due to the question 
not being asked for that age group prior to 2008. Few respond-
ents aged 65+ years reported being vigorously active from 
2008 onward. For those whose total LTPA per week exceeded 
1,680 min, their summed value was re-coded to 1,680 min for 
analysis as recommended in the Australian Health and Welfare 
guidelines (16).
Confounding variables included in the adjusted Cox regres-
sion analyses were sex, age at survey, previous cancer type (none, 
breast, prostate, colorectal, melanoma, other), smoking status 
(never more than 100 cigarettes, ex-smoker, current-smoker), 
fruit and/or vegetable intake (<4, 4–5, 6, 7+ servings daily; based 
on quintile distribution), BMI (<25, 25–29, 30+ kg/m2; adapted 
from World Health Organization classifications), long-term risky 
alcohol intake (none, ≤2 standard drinks, 3+ standard drinks on 
a drinking day; based on National Health and Medical Research 
Council guidelines), SF-8 physical health component score (<50, 
50+; based on median values), SF-8 mental health component 
score (<54, 54+; based on median values), year of survey, and 
self-reported diabetes status. The SF-8 Health Survey component 
of the HWSS is an eight item version of the SF-36®. Higher SF-8 
scores correspond to better functioning.
Two outcomes were investigated following the participants’ 
surveys, namely cancer-specific mortality and all-cause mortality. 
Cancer death was identified using the International Classification 
of Diseases version 10 codes C00-D48, present as either principal 
or other cause of death.
statistical analyses
Differences in baseline characteristics in relation to level of LTPA 
were assessed using the Kruskall–Wallis (for ordinal variables) 
and chi square (for nominal variables) tests.
Person-time was calculated from the date of survey until 
death, or end of follow-up (January 1, 2011), whichever occurred 
first. Cox proportional hazards regression models were used to 
estimate hazard ratios (HR) with 95% confidence intervals (CI) 
for future mortality. Separate analyses were performed for the 
two outcome types (cancer-specific and all-cause mortality), 
with non-cancer mortality being censored in cancer-related 
analyses.
The final adjusted Cox models, which incorporated a stratum 
of “time from cancer diagnosis until survey” for the cancer 
survivor cohort, included LTPA, previous cancer type, age, sex, 
smoking status, BMI, daily fruit and vegetable intake, survey 
year, long-term risky alcohol use, SF-8 physical and mental health 
component scores, and self-reported diabetes. Socioeconomic 
index for areas and region (metro or regional residence) were 
not included in the adjusted model as they were not significantly 
associated with the outcome in crude Cox models.
Differences in survival as a function of prior cancer status (yes/
no) were assessed by combining the CCs and NCCs, and intro-
ducing a variable denoting prior cancer status to the adjusted 
Cox regression model. All aforementioned covariates were also 
included in this model.
Trends for the effects of LTPA on the two outcomes were 
estimated by excluding the categorical LTPA variable from the 
class statement in the adjusted Cox regression model. To test 
for interaction between LTPA and prior cancer status, the two 
cohorts were combined, and interaction terms [LTPA ×  prior 
cancer status (yes/no)] were added to the models.
The proportional hazards assumption that the ratio of mortal-
ity rates according to the exposure variable remained constant for 
the adjusted models was tested by inclusion of an interaction term 
between the LTPA variable and log(survival time). No violation 
of the proportional hazards was observed.
For all analyses, a two sided p < 0.05 was considered statisti-
cally significant. The statistical software SAS 9.3 was used to 
perform all analyses.
resUlTs
Baseline characteristics
At time of survey, the median age for both the CC (n = 1,589) 
and the NCC (n  =  3,145) was 68  years [interquartile range 
(IQR): 60–76 years]. Median BMI was similar between cohorts 
(CC  =  26.6  kg/m2, IQR  =  23.8–29.9; NCC  =  26.0  kg/m2, 
IQR =  23.4–29.2), as was median fruit/vegetable servings per 
day (CC =  5.0 servings, IQR =  4.0–6.0; NCC =  5.0 servings, 
IQR = 4.0–6.0), median SF-8 physical health component score 
(CC = 49.6, IQR = 39.9–54.4; NCC = 51.1, IQR = 42.3–55.6), 
median SF-8 mental health component score (CC  =  54.1, 
IQR = 48.1–57.7; NCC = 54.8, IQR = 49.3–57.7), and percent-
age with self-reported diabetes (CC =  11.8%; NCC =  11.5%). 
Percentage of current smokers (CC = 9.5%; NCC = 10.5%) and 
long-term risky drinking (>2 standard drinks on any given day) 
(CC = 19.8%; NCC = 18.0%) varied slightly between cohorts.
lTPa-stratified Baseline characteristics in 
the cc
Compared with those who reported no LTPA per week, those 
reporting increased levels of LTPA tended to be younger, have 
lower BMI, greater fruit/vegetable and alcohol intake, and 
were less likely to be current smokers (Table 1). Mental health 
component scores from SF-8 questions were appreciably higher 
in the 360+ min of LTPA group and an apparent dose-response 
between increasing levels of LTPA and percentage of those with 
SF-8 physical health component scores above the median was 
observed (Table 1). All of the aforementioned factors were sig-
nificantly associated with LTPA aside from gender and smoking 
status. In terms of time from first cancer diagnosis until survey, 
a slightly higher mean number of years were observed in the “no 
LTPA” group compared to the other LTPA levels. However, no 
significant association between LTPA and “years from cancer 
diagnosis until survey” was observed.
lTPa-stratified Baseline characteristics in 
the ncc
The relationships between LTPA-stratified baseline characteris-
tics for the NCC (Table  2) appeared to mirror those observed 
in the CC; however, significant associations between LTPA and 
TaBle 3 | risk for cancer-specific death and all-cause death by weekly leisure-time physical activity (lTPa) levels, in cohorts with and without 
previously reported cancer diagnosis.
Outcomes following physical activity assessment
cancer-specific death all-cause death
at risk (n) no. of events hazards ratio (hr)a 95% confidence intervals (ci) no. of events hra 95% ci
LTPA (minutes per week)
Cancer cohort (CC)
 None 405 40 Ref. Ref. 67 Ref. Ref.
 <150 443 24 0.62 0.36–1.06 38 0.70 0.46–1.08
 150–359 370 12 0.55 0.28–1.08 18 0.55 0.31–0.97
 360+ 371 7 0.30 0.13–0.70 12 0.41 0.21–0.79
Total participants 1,589 83 135
Non-cancer cohort
 None 801 26 Ref. Ref. 73 Ref. Ref.
 <150 826 13 0.66 0.33–1.31 41 0.78 0.52–1.15
 150–359 774 10 0.54 0.25–1.15 21 0.52 0.32–0.86
 360+ 693 3 0.16 0.05–0.56 17 0.50 0.29–0.88
Total participants 3,145 52 152
aCox model includes age at survey, sex, smoking category, long-term risky drinking category, body mass index category, daily fruit and vegetable intake, survey year, self-reported 
diabetes, SF-8 mental health component score, SF-8 physical health component score, and previous cancer type (for CC).
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gender, and LTPA and smoking status were observed in the NCC 
that were not present within the CC. This may relate in part to the 
greater number of individuals present in the NCC.
cohort Follow-up
The median duration of follow-up after survey was 2.6 years (out 
to 7.6 years) for the cancer survivor cohort, during which time 
83 cancer-specific deaths and 135 all-cause deaths occurred. In 
comparison, a median duration of 2.8 years (out to 7.6 years) for 
the NCC was observed, during which time 52 cancer-specific 
deaths and 152 all-cause deaths occurred.
survival in relation to Prior cancer status
Prior cancer was associated with a threefold increased risk 
[HR =  3.05 (95% CI 2.15–4.33)] for cancer-specific mortality, 
compared to those without prior cancer after adjustment for 
LTPA, age, sex, smoking status, BMI, daily fruit and vegetable 
intake, survey year, long-term risky alcohol use, SF-8 physical 
and mental health component scores, and self-reported diabetes. 
Adjusted estimates of risk for all-cause mortality were 72% higher 
[HR = 1.72 (95% CI 1.36–2.17)] in those with a prior reported 
cancer, compared to those with no prior cancer reported.
lTPa and cancer-specific Mortality
Risks for cancer-specific mortality in participants with prior 
cancer [HR = 0.30 (95% CI 0.13–0.70)] and without prior cancer 
[HR =  0.16 (95% CI 0.05–0.56)] were significantly reduced in 
those reporting 360 min or more of LTPA per week, compared 
to those reporting none (Table 3). For both prior-CCs and NCCs 
there appeared to be an inverse dose–response relationship 
between level of LTPA and risk of cancer-specific mortality (CC 
ptrend =  0.0024; NCC ptrend =  0.0016). However, no significant 
interaction was observed between prior cancer status and LTPA 
in relation to cancer-specific mortality (pinteraction = 0.8341) risk.
lTPa and all-cause Mortality
All-cause mortality during the follow-up period was significantly 
reduced by 45–59% (Table 3) for those reporting 150–359 or 360+ 
min per week of LTPA, regardless of prior cancer status. While not 
significant, results also suggested some reduction in risk for those 
performing less than 150 min LTPA per week. Significant trends 
were observed in terms of effects from increasing levels of LTPA 
on reduction in all-cause mortality, for the cancer (p = 0.0178) 
and non-cancer (p = 0.0215) cohorts. No significant interaction 
was observed between prior cancer status and LTPA in relation 
to all-cause mortality (pinteraction = 0.9932) risk.
DiscUssiOn
This observational study aimed to investigate the relationship 
between LTPA and cancer-specific mortality, and between LTPA 
and all-cause mortality, in two cohorts; a long-term cancer survi-
vor cohort and a cohort without prior recorded cancer who were 
frequency matched on age, gender, and survey year to those in 
the CC. Results confirmed an association between 150  min or 
more LTPA and reduced all-cause mortality in both cohorts. In 
relation to cancer-specific mortality, physical activity exceeding 
360 min per week was associated with survival benefits regardless 
of a person’s prior cancer status. Lower levels of physical activity 
(<150, 150–359 min per week) were not significantly associated 
with reductions in cancer-specific mortality in those with or 
without a prior cancer.
Physical activity has previously been shown to provide 
immediate beneficial effects for cancer survivors, including 
improvements in physiological markers, body composition, 
physical function, fatigue, and psychological outcomes (2, 
17–20). Although evidence related to long-term cancer survivors 
is sparse, a recent study by Inoue-Choi et al. (13) suggested adher-
ence to recommended levels of physical activity in long-term 
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cancer survivors may improve all-cause, CVD-specific, and 
cancer-specific mortality. While the study variables and design 
used by Inoue-Choi et al. differed to those in our study in that 
we included men and women, a comparative non-cancer group, 
and different doses of physical activity (e.g., 150, 150–359, and 
360+ min per week), it was of interest to note the clear protec-
tive (adjusted) effects of physical activity that existed for both 
cancer-specific and all-cause mortality outcomes in their study. 
Similarly, a recent prospective cohort study (21) of 830 long-term 
prostate cancer survivors assessed physical activity at 2.5, 4.7, and 
6.8 years post-diagnosis (comparable to the 8.8-year assessment 
time point in our study) showed a protective effect of increased 
physical activity and prostate cancer mortality. In our study, the 
likelihood of cancer-related death for cancer survivors appeared 
to decrease for increasing levels of physical activity culminating 
in a significant 70% reduced risk for those performing 360+ min 
of LTPA per week. In the same exposure group (360+ min), all-
cause mortality in cancer survivors was reduced by almost 60%.
In our cohort containing individuals with and without 
prior cancer, we observed a 72% increased all-cause mortality 
risk over the follow-up period in cancer survivors compared 
to those without a prior cancer. We also observed a threefold 
increased risk for cancer-specific mortality in those with prior 
cancer compared to cancer-naive participants. Higher risk of 
non-cancer-related mortality may in part be explained by an 
overrepresentation of CVD risk factors being observed in cancer 
survivors (22). Although it would have been interesting to test 
for CVD-specific mortality, we did not investigate this due to the 
relatively low numbers of cancer survivors having a CVD-specific 
death recorded and the likelihood of competing risks between the 
CVD and cancer mortality outcomes.
For long-term cancer survivors, previous evidence suggests an 
increased risk for both cancer and non-cancer-related mortality 
compared to that of the general population (23, 24). A number of 
studies have highlighted the above average incidence of second 
primary or recurrent cancers in those surviving an initial cancer 
(25). This increased risk for subsequent cancer appears to depend 
upon cancer type and/or cancer treatment, and other individual-
specific risk profiles (e.g., lifestyle, genetics, and other exposures) 
(25). In addition, increases in all-cause and non-cancer-related 
mortality in cancer survivors have been reported (13). There are 
a number of mechanisms by which physical activity may further 
improve cancer-specific survival in long-term cancer survivors 
as well as those without prior cancer. Since both cohorts (those 
with and those without prior cancer) observed apparent cancer-
specific survival benefits from physical activity, one explanation 
might be that physical activity reduces the likelihood of cancer 
incidence, resulting in fewer cancer deaths. However, in some 
unpublished analyses from this study we observed no significant 
relationship between physical activity and cancer incidence (or 
second primary cancer incidence in the prior-CC). An alternative 
explanation is that physical activity may play a role in improving 
prognosis of those who develop an incident or second primary 
cancer. Evidence supporting this has been reported by a number 
of researchers (26). Although the biological mechanisms through 
which this is achieved are still unclear, there are a number of 
promising avenues. The influence of exercise on host factors such 
as metabolic hormones, inflammation/cytokines, and immune 
surveillance have been suggested, as have exercise’s effects on cer-
tain tumor-related factors such as p27, CTNNB1, CACNA2D3, 
and L3MBTL1 (26).
By selecting an NCC from the same source cohort who 
possessed similar age and gender distributions as the cancer 
survivors, we investigated whether differential physical activity-
related effects on our two outcomes (cancer mortality and 
all-cause mortality) might exist. Certainly, physical activity has 
been associated with reduced all-cause mortality rates (27) and 
cardiovascular-related disease (28–30) or cardiovascular-death 
(31) in population-based cohorts. Results from our study of a 
positive association between physical activity and decreasing 
cancer-specific and all-cause mortality in our NCC reflected 
previous findings. Moreover, our results suggested the benefits of 
moderate to high levels of physical activity in decreasing cancer-
specific and all-cause mortality were comparable between those 
with or without a prior cancer. From a health promotion and 
management perspective, this provides a degree of confirmation 
that physical activity recommendations for the general public are 
applicable and beneficial for cancer survivors. Moreover, these 
benefits were observed in an aggregate cancer survivor group 
and, while cancer type was accounted for in the analyses, it is 
likely these benefits of physical activity would apply broadly to 
survivors of most cancer types.
There are a number of strengths attributable to this study. 
Foremost was our ability to gain all recorded retrospective and 
post-survey cancer and mortality records for those who partici-
pated in the survey. This allowed an assessment of physical activity 
levels an average 8.8 years following cancer survivors’ initial cancer 
diagnoses. Second, the in-depth survey of participants allowed 
adjustment of numerous confounding variables associated with 
lifestyle, physical, and mental health, which provides a greater 
reliability in estimating the association between physical activity 
and the outcomes of interest. In addition, access to non-cancer 
survey participants (at time of survey) enabled comparison of 
physical activity influences on the outcomes in participants with 
and without a prior cancer. It is unlikely there would be many 
instances of misclassification of cancer outcomes as these were 
mostly derived from pathology laboratories or radiation oncolo-
gists (32). For similar reasons, mortality records are unlikely to 
be a basis for misclassification bias.
Some limitations exist with this study. Given the self-reported 
nature of the physical activity measurements, some misclassifica-
tion of the exposure might exist. Any associated bias is likely 
reduced by the use of quite broad categories for physical activity 
(0, <150, 150–59, 360+ min per week) and is unlikely to relate to 
the outcomes due to the prospective nature of the study. While 
it made sense to classify physical activity based on recommenda-
tions and health promotion messages, our aggregation of low, 
moderate, and vigorous physical activity in calculating amount 
of LTPA per week excluded our ability to measure differences 
in effectiveness between low, moderate, and vigorous levels of 
physical activity. Moreover, although we adjusted for a number 
of potential confounders in our analyses, possible confounding 
may still exist and contribute to the identified associations. In 
addition, loss to follow-up (between survey and outcome) would 
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likely have been minimal since the individuals were followed 
up through the Western Australian Health registries—in terms 
of cancer and/or death. This means that virtually all deaths and 
cancers reported throughout the follow-up period would be 
included; however, those occurring outside of Western Australia 
would presumably be lost to follow-up. Finally, the observational 
nature of the study does not permit us to infer cause and effect.
In summary, this study suggests physical activity is associated 
with improved cancer-specific and all-cause survival in long-
term survivors of cancer. These associations were comparable in 
magnitude to those seen in a NCC of similar age and gender, 
selected from the same source population. Evidence also sug-
gested further benefits in survival may be achieved by those 
exceeding 360 min of LTPA per week, regardless of an individual’s 
prior cancer status.
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